Glyburide Tablet
Product Images NDC 72241-040

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 72241-040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Modavar Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container-label-100s-count-1-25mg.jpg (Container Label 100s Count 1 25mg)

Container-label-100s-count-1-25mg.jpg (Container Label 100s Count 1 25mg)
Each tablet of Modavar's Glyburide Tablets, USP contains 1.25 mg of glyburide, USP. It is recommended to store the tablets between 20 to 25 degrees Celsius, with excursions permitted between 15 to 30 degrees Celsius. The medicine should be kept out of the reach of children, in a tightly closed container. The manufacturer is Cadia Pharmaceuticals Limited, located in Gujarat, India. The medication is available by prescription only and should be dispensed in a tight, light-resistant container as defined. Further details are not available as the text is partially garbled.*
FDA Label Image

Container-label-100s-count-2-5mg (Container Label 100s Count 2 5mg)

FDA Label Image

Container-label-100s-count-5mg.jpg (Container Label 100s Count 5mg)

Container-label-100s-count-5mg.jpg (Container Label 100s Count 5mg)
This is a prescription medication with NDC code 72241-040-05 marketed under the brand name GlyBURIDE. It comes in tablet form and each tablet contains 5 mg of Glyburide, USP. The medication is used to treat diabetes. The usual dosage and instructions are provided with the accompanying packaging. It should be stored at controlled room temperature and dispensed in a tightly closed container. This medication is manufactured by Cadia Pharmaceutical Limited in India and distributed by Modavar Pharmaceuticals LLC in Washington, DC.*
FDA Label Image

Glyburide-fig-1 (Glyburide Fig 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.